Duncan Barbara Gayle

CIK 000135312811 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001353128

Recent Transactions

50 trades

Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2025-06-20+41,200→ 41,200 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2025-06-20+29,600→ 62,750 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2025-06-20−29,600→ 0 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2025-06-20+29,600→ 29,600 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-05-01+5,750→ 5,750 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-05-01+4,165→ 19,919 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (right to buy)
2025-02-20+45,000→ 45,000 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (Right to Buy)
2024-12-12+90,000→ 90,000 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2024-06-21+29,600→ 29,600 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2024-06-21+41,200→ 41,200 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2024-06-16+33,150→ 33,150 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2024-06-16−33,150→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−17,000→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−30,000→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−17,000→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−17,000→ 0 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2024-04-25+8,804→ 8,804 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-04-25+6,501→ 15,754 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (Right to Buy)
2024-02-22+30,000→ 30,000 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2023-06-16+46,750→ 46,750 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2023-06-16+33,150→ 33,150 total
Award
Fusion Pharmaceuticals Inc.
Stock Opion (Right to Buy)
2023-06-14+17,000→ 17,000 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2023-05-05+8,065→ 9,253 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2023-05-05+11,371→ 11,371 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−15,700→ 0 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−20,000→ 0 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−34,271→ 0 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−13,550→ 0 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−15,700→ 0 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−15,700→ 0 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−10,840→ 0 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (Right to Buy)
2023-02-23+15,000→ 15,000 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2023-02-03+1,188→ 1,188 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to purchase Ordinary Shares
2022-07-01+500,000→ 500,000 total
Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-24+20,000→ 20,000 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2022-06-17+61,264→ 61,264 total
Award
Fusion Pharmaceuticals Inc.
Stock Opion (Right to Buy)
2022-06-14+17,000→ 17,000 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (Right to Buy)
2022-04-08+21,347→ 21,347 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (Right to Buy)
2022-02-03+15,000→ 15,000 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to purchase Ordinary Shares
2021-07-01+379,788→ 379,788 total
Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-18+15,700→ 15,700 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2021-06-18+34,025→ 34,025 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (Right to Buy)
2021-06-11+15,000→ 15,000 total
Award
Fusion Pharmaceuticals Inc.
Stock Opion (Right to Buy)
2021-06-04+17,000→ 17,000 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (Right to Buy)
2021-05-17+1,750→ 1,750 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2020-10-30+30,000→ 30,000 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2020-10-29+80,000→ 80,000 total
Disposition to Issuer
IMMUNOMEDICS INC
Common Stock
2020-10-23−49,244→ 0 total
Disposition to Issuer
IMMUNOMEDICS INC
Restricted Stock Unit
2020-10-23−3,718→ 0 total
Disposition to Issuer
IMMUNOMEDICS INC
Stock Option (Right to Buy)
2020-10-23−6,540→ 0 total

Companies

Recent Filings

Address

C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES STREET

NEW YORK, NY, 10013

View on SEC.gov